|
A Milestone of Full Corporate Tax Payment and Continuous Innovation
2017.08.02
|
|---|
|
The company announced on July 13 the results of a comprehensive corporate tax investigation through an official disclosure and completed the full payment of corporate tax amounting to 15.67 billion KRW on July 31.
After completing the tax payment, the company plans to file an appeal and a petition for review in accordance with the Framework Act on National Taxes. Taking this integrated tax audit as an opportunity, Daehan New Pharm is pursuing greater internal soundness by innovating its management systems and focusing on research and development.
The company’s sales grew by 7.8% in 2012 and 18.1% in 2013, maintaining an impressive annual growth rate of over 20% for three consecutive years starting in 2014.
This strong growth has been driven by a well-structured product portfolio and differentiated therapeutic solutions that established Daehan New Pharm as a leader in the obesity and wellness pharmaceutical segments. In addition, continuous R&D efforts have enabled the company to expand its product lines into chronic disease treatments such as hypertension and hyperlipidemia.
Since 2013, the company has also been investing aggressively in biotechnology, establishing a serum-free culture medium production facility in the Hyangnam Pharmaceutical Complex to provide customized media to clients. The company’s Central R&D Center in Hyangnam and its affiliated research institute in Osong are collaborating closely to carry out various bio-research projects.
Daehan New Pharm’s focus on biotechnology stems from its strategy to combine its established strengths in obesity and wellness pharmaceuticals with the bio sector, thereby creating business synergy and new growth engines for the future.
To further strengthen sales and R&D, the company continues to steadily expand its recruitment each year. Notably, all 341 employees at Daehan New Pharm are full-time regular employees—a policy aligned with the company’s management philosophy of fostering a “warm and inclusive workplace.”
Every member of the organization is dedicated to sustaining the company’s strong growth trajectory and will continue to drive the momentum of innovation that has been built over the years. |


Home